Compared with the control group, serum high–sensitivity C–reactive protein and plasma endothelin–1 levels were significantly lower and adiponectin level significantly higher in patients in the pioglitazone group.

Serum adiponectin level was negatively correlated with plasma endothelin–1 level and coronary plaque area (r=0.739 and –0.431, respectively, both P<0.05).